Finzati - Logo
CDNA logo

CareDx, Inc

CDNA • Medical - Diagnostics & Research
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.97B
Growth
7.5%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 5.9%Positive free cash flow · 0.68Manageable debt level · 0.06Healthy liquidity · 2.86Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$1.97B
52W Range11.26 - 40.47
Beta2.43
Gross Margin66.99%
Oper. Margin-5.53%
Profit Margin-5.62%
Debt/Eq0.06
Current Ratio2.86
Quick Ratio2.56
Revenue 5Y7.53%

Investment DNA

How strong this company looks for long-term investors

56
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
85/100
Price Attractiveness
Cheap or expensive today
71/100
Why this score▼
Positive revenue growth · 5.9%Positive free cash flow · 0.68Manageable debt level · 0.06Healthy liquidity · 2.86Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$35.00
Mean
$42.00
Median
$45.00
High
$46.00

Company Overview

IPO: 7/17/2014
Industry: Medical - Diagnostics & Research
P/B i: 3.31
Debt / Equity i: 0.06
Operating Margin: -5.53%
Net Margin: -5.62%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.06
Current Ratio: 2.86
Quick Ratio: 2.56
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Valantine Hannah
Transaction: 07/16/2026
SELL
Change
-16,048
Price
$14.19
Filing
07/17/2026
Type
SELL
Valantine Hannah
Transaction: 07/16/2026
SELL
Change
-100
Price
$36.55
Filing
07/17/2026
Type
SELL
Hanna John Walter JR
Transaction: 07/16/2026
SELL
Change
-118,000
Price
$8.20
Filing
07/17/2026
Type
SELL